Aleph Farms clears Singapore for cultivated beef, first approval outside Israel

Aleph Farms grows whole-cut cultivated beef from non-modified cow cells in controlled bioreactors and combines them with a soy and wheat matrix to make its Thin-Cut Steak under the Aleph Cuts brand.

That whole-cut steak, not minced patties, is where cultivated meat becomes a real business — and that winning regulators market by market builds the category.

Founded in 2017 and led by co-founder and CEO Didier Toubia, Aleph Farms grows beef from cells of a premium Black Angus cow. Toubia says the aim is to complement conventional beef supply chains rather than replace them, which shapes how the company pursues regulators, partners and markets.

Aleph received the world's first cultivated beef approval from Israel's Ministry of Health, announced in January 2024, then filed in further markets. In January 2026 it made Singapore its Asia-Pacific scale-up hub through a contract development and manufacturing agreement with Cell Agritech — an asset-light model for regional production — and it has also worked with BBGI and Fermbox Bio on Thailand's first cultivated meat plant. The company had raised $147M as of the Singapore approval.

Regulatory approval is secured, production is next: the Singapore Food Agency clearance in August 2026 makes Aleph the only company cleared to sell cultivated beef in any market, and its Singapore production line is expected to be operational in the first half of 2027.

Aleph chose steak — the whole-cut structure other developers avoided — so its regulatory approvals had no precedent to copy and competitors could not follow on a technical shortcut.

It treated regulators as the go-to-market channel: Israel first in 2024, Singapore in 2026, with filings across five more markets, so each approval compounds the next.

The asset-light model — contract manufacturing with Cell Agritech in Singapore — keeps capital down while production scales, avoiding its own factories.

Aleph positions cultivated beef as a complement to conventional supply, a message that eases regulatory and foodservice conversations in import-dependent markets like Singapore.

Pick the product competitors can't copy cheaply: whole-cut steak made Aleph the first and still only producer with cultivated beef approved anywhere, and each win becomes the next market's precedent.

As of August 2026 Aleph Farms holds the only regulatory approvals for cultivated beef anywhere in the world, with its Singapore production line expected to operate in the first half of 2027 through the Cell Agritech agreement and initial launches through restaurant partners. Filings are pending in Thailand, Switzerland and the UK, with the EU and UAE signalled as future targets, and the company frames its second-market approval as proof that its safety and quality work satisfies a second rigorous regulator — the foundation for the approvals still to come.